Physics and AI Driven Precision Engineering of Novel Drugs

Health + Time : Priceless

We Engineer New Treatments Atom by Atom

To help you live healthier, longer

First-in-Class Drug Candidates to Change the Standard of Care for Every Disease We Address
More about our pipeline
Recent News
Our stories
Verseon CEO Adityo Prakash Discusses Transforming Drug Discovery to Find the Breakthrough Treatments of Tomorrow
"It starts not with AI but with fundamental quantum physics breakthroughs we call Deep Quantum Modeling."
November 18, 2025
Verseon's Innovations in Neural Network Architectures Offer Superior Solutions for Life Sciences
In two papers, Verseon demonstrates superior predictions for drug-protein interactions and more accurate estimates of biological age
November 6, 2025
Verseon: Expanding the Frontiers of Drug Discovery
How one company plans to change billions of lives
October 29, 2025
How Verseon is Rewriting the Future of Drug Discovery
IBT feature describes Verseon's unconventional development path that has led to breaking the bottle next of drug discovery
August 22, 2025
Verseon's Deep Quantum Modeling: Shifting the Drug Discovery Paradigm
CEO Adityo Prakash describes the advances in physics modeling and AI that drive the company's systematic discovery of promising drug candidates
May 26, 2025
Verseon Presents Two AI Innovations at the 2025 IEEE Conference on Artificial Intelligence
Verseon's innovations compensate for missing or imperfect data and combine separate AI models to enhance predictive accuracy
May 9, 2025
Verseon: Combining Deep Quantum Modeling™ and AI to Find Breakthrough Drugs
Verseon’s CEO Adityo Prakash discusses the role of the company’s Deep Quantum Modeling™ of protein-drug interactions with Pharmaceutical Executive’s Mike Hollan
April 14, 2025
VersAI's Unique Neural Network Architecture Marks a Major Leap Forward for Drug Discovery AI
Drug Discovery World's editor Reece Armstrong and Verseon's CEO Adityo Prakash discuss the implications of different AI neural network architectures for drug discovery
March 25, 2025
Verseon CEO Adityo Prakash Discusses Transforming Drug Discovery to Find the Breakthrough Treatments of Tomorrow
"It starts not with AI but with fundamental quantum physics breakthroughs we call Deep Quantum Modeling."
November 18, 2025
Verseon's Innovations in Neural Network Architectures Offer Superior Solutions for Life Sciences
In two papers, Verseon demonstrates superior predictions for drug-protein interactions and more accurate estimates of biological age
November 6, 2025
Verseon: Expanding the Frontiers of Drug Discovery
How one company plans to change billions of lives
October 29, 2025
How Verseon is Rewriting the Future of Drug Discovery
IBT feature describes Verseon's unconventional development path that has led to breaking the bottle next of drug discovery
August 22, 2025
Verseon's Deep Quantum Modeling: Shifting the Drug Discovery Paradigm
CEO Adityo Prakash describes the advances in physics modeling and AI that drive the company's systematic discovery of promising drug candidates
May 26, 2025
Verseon Presents Two AI Innovations at the 2025 IEEE Conference on Artificial Intelligence
Verseon's innovations compensate for missing or imperfect data and combine separate AI models to enhance predictive accuracy
May 9, 2025
Verseon: Combining Deep Quantum Modeling™ and AI to Find Breakthrough Drugs
Verseon’s CEO Adityo Prakash discusses the role of the company’s Deep Quantum Modeling™ of protein-drug interactions with Pharmaceutical Executive’s Mike Hollan
April 14, 2025
VersAI's Unique Neural Network Architecture Marks a Major Leap Forward for Drug Discovery AI
Drug Discovery World's editor Reece Armstrong and Verseon's CEO Adityo Prakash discuss the implications of different AI neural network architectures for drug discovery
March 25, 2025
More News
Changing everything the world can expect from 21st Century Medicine
Continue to Company